Stocks In News - USFDA
- Lupin Ltd:-
- Lupin Ltd's US-based subsidiary, Gavis Pharmaceuticals LLC., has received final approval from the US health regulator for its Voriconazole tablets, 50 mg & 200 mg and Voriconazole Oral Suspension, 40 mg/mL, used in the treatment of fungal infections.
- Natco Pharma Limited:-
- Natco Pharma Limited said that its marketing partner, Mylan Inc. has received a tentative approval from USFDA for its Abbreviated New Drug Application (ANDA) for Sorafenib Tablets.
- This product is the generic version of NEXAVAR®, which is indicated for the treatment of certain types of cancers including unresectable hepatocellular carcinoma and advanced renal cell carcinoma.
No comments:
Post a Comment